Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Lymphoma, Follicular 1 COVID-19 1

Interventions

Surveys and Questionnaires 6 Standard of Care 6 Blood Specimen Collection 6 BNT162 Vaccine 5 Hydroxychloroquine 4 Surgical Procedures, Operative 3 Specimen Handling 3 Practice Guidelines as Topic 3 COVID-19 Vaccines 3 2019-nCoV Vaccine mRNA-1273 3 tocilizumab 2 sotrovimab 2 Pandemic Preparedness 2 CVnCoV COVID-19 vaccine 2 Azithromycin 2 sinovac COVID-19 vaccine 1 selinexor 1 remdesivir 1 ogalvibart 1 monalizumab 1 lenzilumab 1 heterologous prime boost COVID-19 vaccination 1 crexavibart 1 cilgavimab and tixagevimab drug combination 1 ciclesonide 1 avdoralimab 1 XAV-19 1 Therapeutics 1 Telemedicine 1 Sperm Count 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × COVID-19 × COVID-19 Serotherapy × Clear all

NCT04873414 2021-06-02

PlaSenTer

National Institute of Health Research and Development, Ministry of Health Republic of Indonesia

Phase 2/3 Unknown

COVID-19, Lymphoma, Follicular

Data powered by HemOnc (CC BY 4.0) Colophon ⚡